Effects of induction with novel agentsversusconventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma-Reference-Cited by-同舟云学术

Effects of induction with novel agentsversusconventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma

Published:2009-12-28 Issue:2 Volume:51 Page:243-251
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Benson Don M.,Panzner Kathryn,Hamadani Mehdi,Hofmeister Craig C.,Bakan Courtney E.,Smith Megan K.,Elder Pat,Krugh David,O'Donnell Lynn,Devine Steven M.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428190903480728

Reference28 articles.

1. Cancer Statistics, 2008

2. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

3. Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

4. Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

5. Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma;Clinical oncohematology;2019

2. Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response;Clinical Lymphoma Myeloma and Leukemia;2018-08

3. Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma;Journal of Clinical Apheresis;2017-10-05

4. Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression;Pathology & Oncology Research;2015-05-14

5. Autologous Transplantation and Maintenance Therapy in Multiple Myeloma;New England Journal of Medicine;2014-09-04